Tumor necrosis factor-α causes accumulation of a ubiquitinated form of hypoxia inducible factor-1α through a nuclear factor-κB-dependent pathway

Molecular Biology of the Cell

Volumn 14, Issue 6, 2003, Pages 2216-2225

  Zhou, Jie ^a   Schmid, Tobias ^a   Brüne, Bernhard ^a  

^a University of Koblenz Landau   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; ETICYCLIDINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; PROTEIN P50; SALAZOSULFAPYRIDINE; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CONTROLLED STUDY; EMBRYO; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; KIDNEY CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA TRANSLATION; SIGNAL TRANSDUCTION;

HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NF-KAPPA B; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN;

EID: 0038308573     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E02-09-0598     Document Type: Article

References (35)

1. Albina, J.E., Mastrofrancesco, B., Vessella, J.A., Louis, C.A., Henry, W.L., Jr., and Reichner, J.S. (2001). HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha. Am. J. Physiol. Cell Physiol. 281, C1971-C1977.
2. Alvarez-Tejado, M., Alfranca, A., Aragones, J., Vara, A., Landazuri, M.O., and del Peso, L. (2002). Lack of evidence for the involvement of the phosphoinositide 3-kinase/akt pathway in the activation of hypoxia-inducible factors by low oxygen tension. J. Biol. Chem. 277, 13508-13517.
3. Arsham, A.M., Plas, D.R., Thompson, C.B., and Simon, M.C. (2002). Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1alpha nor sufficient for HIF-1-dependent target gene transcription. J. Biol. Chem. 277, 15162-15170.
4. Baud, V., and Karin, M. (2001). Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372-377.
5. Chan, D.A., Sutphin, P.D., Denko, N.C., and Giaccia, A.J. (2002). Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J. Biol. Chem. 277, 40112-40117.
6. El Awad, B., Kreft, B., Wolber, E.M., Hellwig-Burgel, T., Metzen, E., Fandrey, J., and Jelkmann, W. (2000). Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in human proximal tubular cells. Kidney Int. 58, 43-50.
7. Gorlach, A., Diebold, I., Schini-Kerth, V.B., Berchner-Pfannschmidt, U., Roth, U., Brandes, R.P., Kietzmann, T., and Busse, R. (2001). Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ. Res. 89, 47-54.
8. Haddad, J.J., and Land, S.C. (2001). A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett. 505, 269-274.
9. Hellwig-Bürgel, T., Rutkowski, K., Metzen, E., Fandrey, J., and Jelkmann, W. (1999). Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94, 1561-1567.
10. Hur, E., Chang, K.Y., Lee, E., Lee, S.K., and Park, H. (2001). Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the transactivation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha. Mol. Pharmacol. 59, 1216-1224.
11. 2 sensing. Science 292, 464-468.
12. 2-regulated prolyl hydroxylation. Science 292, 468-472.
13. Kallio, P.J., Wilson, W.J., O'Brien, S., Makino, Y., and Poellinger, L. (1999). Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519-6525.
14. Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J., and Whitelaw, M.L. (2002). Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295, 858-861.
15. Laughner, E., Taghavi, P., Chiles, K., Mahon, P.C., and Semenza, G.L. (2001). HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21, 3995-4004.
16. Meng, F., Liu, L., Chin, P.C., and D'Mello, S.R. (2002). Akt is a downstream target of NF-kappa B. J. Biol. Chem. 277, 29674-29680.
17. Napoli, C., de Nigris, F., and Palinski, W. (2001). Multiple role of reactive oxygen species in the arterial wall. J. Cell Biochem. 82, 674-682.
18. Palmer, L.A., Gaston, B., and Johns, R.A. (2000). Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol. Pharmacol. 58, 1197-1203.
19. Richard, D.E., Berra, E., Gothie, E., Roux, D., and Pouyssegur, J. (1999). p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 274, 32631-32637.
20. Salceda, S., and Caro, J. (1997). Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J. Biol. Chem. 272, 22642-22647.
21. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
22. Sandau, K.B., Fandrey, J., and Brüne, B. (2001a). Accumulation of HIF-1 alpha under the influence of nitric oxide. Blood 97, 1009-1015.
23. Sandau, K.B., Zhou, J., Kietzmann, T., and Brune, B. (2001b). Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. J. Biol. Chem. 276, 39805-39811.
24. Sang, N., Fang, J., Srinivas, V., Leshchinsky, I., and Caro, J. (2002). Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP. Mol. Cell. Biol. 22, 2984-2992.
25. Semenza, G.L. (2002). HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8, S62-S67.
26. Stiehl, D.P., Jelkmann, W., Wenger, R.H., and Hellwig-Burgel, T. (2002). Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. FEBS Lett. 512, 157-162.
27. Thornton, R.D., Lane, P., Borghaei, R.C., Pease, E.A., Caro, J., and Mochan, E. (2000). Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem. J. 350, 307-312.
28. Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G.L., and Van Obberghen, E. (2002). Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J. Biol. Chem. 277, 27975-27981.
29. Wahl, C., Liptay, S., Adler, G., and Schmid, R.M. (1998). Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest. 101, 1163-1174.
30. Wang, G.L., and Semenza, G.L. (1995). Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230-1237.
31. 2 tension. Proc. Natl. Acad. Sci. USA 92, 5510-5514.
32. Weber, C.K., Liptay, S., Wirth, T., Adler, G., and Schmid, R.M. (2000). Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology 119, 1209-1218.
33. Yu, F., White, S.B., Zhao, Q., and Lee, F.S. (2001). HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98, 9630-9635.
34. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M., Simons, J.W., and Semenza, G.L. (2000). Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase /PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541-1545.
35. Zhu, H., Jackson, T., and Bunn, H.F. (2002). Detecting and responding to hypoxia. Nephrol. Dial. Transplant. 17(suppl 1), 3-7.